DEF 14AThe Ballot
Travere Therapeutics, Inc. files DEF 14A
Filed Apr 14, 2017 · 9y ago · Accession 0001438533-17-000013
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Travere Therapeutics, Inc.
- Ticker
- TVTX
- CIK
- 1438533
- Form type
- DEF 14A
- Filing date
- Apr 14, 2017
- Report date
- May 17, 2017
- Document
- rtrx-2017xproxy.htm
- Size
- 1.3 MB